Rhythm Pharmaceuticals

Rhythm Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for rare genetic disorders of obesity. They generate revenue primarily through the sale of their FDA-approved drug, IMCIVREE, which targets specific genetic deficiencies that lead to severe obesity. Founded in 2008, the company has made significant strides in the field of precision medicine, with a strong emphasis on genetic research and patient-specific treatments. Their mission is to transform the lives of patients suffering from rare genetic conditions by providing targeted therapies that address the underlying causes of their diseases.

Recent Posts by Rhythm Pharmaceuticals

1-20 of 71